Gut microbiota and outcomes in DLBCL, NFIA-ETO2 fusion cooperates with TP53 in leukemogenesis, and the impact of nirmatrelvir + ritonavir on CLL patient outcomes during the Omicron surge
Blood Podcast
00:00
Norma Treviere and Ratanavir for CLL Testing Positive for SARS-CoV-2
January 2 was the date that Norma Treviere was first available to patients in a Danish healthcare system. During that study period, outpatient SARS-CoV-2 infections occurred in 1080 out of 2,929 active patients with CLL. About two-thirds were male, and the median age was 71 years. The relative risk reduction was 69% in patients who were 65 years or older who received NormaTreve.
Transcript
Play full episode
